These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19497737)

  • 41. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives.
    Peng HK; Lin CK; Yang SY; Tseng CK; Tzeng CC; Lee JC; Yang SC
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1107-10. PubMed ID: 22204909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of thiazolone-based sulfonamides as inhibitors of HCV NS5B polymerase.
    Ding Y; Smith KL; Varaprasad CV; Chang E; Alexander J; Yao N
    Bioorg Med Chem Lett; 2007 Feb; 17(3):841-5. PubMed ID: 16990004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay.
    Stammers TA; Coulombe R; Duplessis M; Fazal G; Gagnon A; Garneau M; Goulet S; Jakalian A; LaPlante S; Rancourt J; Thavonekham B; Wernic D; Kukolj G; Beaulieu PL
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6879-85. PubMed ID: 24176401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections.
    Beaulieu PL; Tsantrizos YS
    Curr Opin Investig Drugs; 2004 Aug; 5(8):838-50. PubMed ID: 15600240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase.
    Habermann J; Capitò E; Ferreira Mdel R; Koch U; Narjes F
    Bioorg Med Chem Lett; 2009 Feb; 19(3):633-8. PubMed ID: 19109015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative Molecular Field Analysis and Molecular Docking Studies on Quinolinone Derivatives Indicate Potential Hepatitis C Virus Inhibitors.
    Malathi K; Ramaiah S; Anbarasu A
    Cell Biochem Biophys; 2019 Jun; 77(2):139-156. PubMed ID: 30796723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase.
    Stansfield I; Ercolani C; Mackay A; Conte I; Pompei M; Koch U; Gennari N; Giuliano C; Rowley M; Narjes F
    Bioorg Med Chem Lett; 2009 Feb; 19(3):627-32. PubMed ID: 19131244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazines.
    Wagner R; Larson DP; Beno DW; Bosse TD; Darbyshire JF; Gao Y; Gates BD; He W; Henry RF; Hernandez LE; Hutchinson DK; Jiang WW; Kati WM; Klein LL; Koev G; Kohlbrenner W; Krueger AC; Liu J; Liu Y; Long MA; Maring CJ; Masse SV; Middleton T; Montgomery DA; Pratt JK; Stuart P; Molla A; Kempf DJ
    J Med Chem; 2009 Mar; 52(6):1659-69. PubMed ID: 19226162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
    Randolph JT; Flentge CA; Huang PP; Hutchinson DK; Klein LL; Lim HB; Mondal R; Reisch T; Montgomery DA; Jiang WW; Masse SV; Hernandez LE; Henry RF; Liu Y; Koev G; Kati WM; Stewart KD; Beno DW; Molla A; Kempf DJ
    J Med Chem; 2009 May; 52(10):3174-83. PubMed ID: 19402666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus.
    Chen YL; Tang J; Kesler MJ; Sham YY; Vince R; Geraghty RJ; Wang Z
    Bioorg Med Chem; 2012 Jan; 20(1):467-79. PubMed ID: 22100256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current perspective of HCV NS5B inhibitors: a review.
    Patil VM; Gupta SP; Samanta S; Masand N
    Curr Med Chem; 2011; 18(36):5564-97. PubMed ID: 22172066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors.
    Ontoria JM; Rydberg EH; Di Marco S; Tomei L; Attenni B; Malancona S; Martin Hernando JI; Gennari N; Koch U; Narjes F; Rowley M; Summa V; Carroll SS; Olsen DB; De Francesco R; Altamura S; Migliaccio G; Carfì A
    J Med Chem; 2009 Aug; 52(16):5217-27. PubMed ID: 19877603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 6-Hydrazinopurine 2'-methyl ribonucleosides and their 5'-monophosphate prodrugs as potent hepatitis C virus inhibitors.
    Gunic E; Chow S; Rong F; Ramasamy K; Raney A; Li DY; Huang J; Hamatake RK; Hong Z; Girardet JL
    Bioorg Med Chem Lett; 2007 May; 17(9):2456-8. PubMed ID: 17331718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of anthranilic acid derivatives as a novel class of allosteric inhibitors of hepatitis C NS5B polymerase.
    Nittoli T; Curran K; Insaf S; DiGrandi M; Orlowski M; Chopra R; Agarwal A; Howe AY; Prashad A; Floyd MB; Johnson B; Sutherland A; Wheless K; Feld B; O'Connell J; Mansour TS; Bloom J
    J Med Chem; 2007 May; 50(9):2108-16. PubMed ID: 17402724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase.
    Laporte MG; Lessen TA; Leister L; Cebzanov D; Amparo E; Faust C; Ortlip D; Bailey TR; Nitz TJ; Chunduru SK; Young DC; Burns CJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):100-3. PubMed ID: 16260131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quinolones as HCV NS5B polymerase inhibitors.
    Kumar DV; Rai R; Brameld KA; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Shaghafi MB; Hu H; Lehoux I; To N; Young WB; Green MJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):82-7. PubMed ID: 21145235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase.
    Di Francesco ME; Avolio S; Pompei M; Pesci S; Monteagudo E; Pucci V; Giuliano C; Fiore F; Rowley M; Summa V
    Bioorg Med Chem; 2012 Aug; 20(15):4801-11. PubMed ID: 22770556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.
    Hassan GS; Georgey HH; Mohammed EZ; Omar FA
    Eur J Med Chem; 2019 Dec; 184():111747. PubMed ID: 31604164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.
    Bhatt A; Gurukumar KR; Basu A; Patel MR; Kaushik-Basu N; Talele TT
    Eur J Med Chem; 2011 Oct; 46(10):5138-45. PubMed ID: 21893371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and anti-HCV activity of 3',4'-oxetane nucleosides.
    Chang W; Du J; Rachakonda S; Ross BS; Convers-Reignier S; Yau WT; Pons JF; Murakami E; Bao H; Steuer HM; Furman PA; Otto MJ; Sofia MJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4539-43. PubMed ID: 20580554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.